Limited O-specific polysaccharide (OSP)-specific functional antibody responses in young children with Shigella

Insights

Young children develop weaker antibody responses to Shigella infection, hindering innate immune cell activation and increasing disease severity. This highlights a critical gap in protection against shigellosis in endemic areas.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pediatrics

Background:

  • Shigellosis is a major cause of childhood diarrhea deaths globally, with no effective vaccine currently available.
  • Existing vaccine candidates have shown limited efficacy in young children, particularly in endemic regions.
  • Understanding protective immune responses against Shigella in young children is crucial for vaccine development.

Purpose of the Study:

  • To define Shigella-specific antibody responses in young children compared to older individuals in a Shigella-endemic area.
  • To investigate functional antibody profiles, including Fc receptor (FcR) binding and innate immune cell activation.
  • To identify correlates of protection against Shigella infection and severe shigellosis in different age groups.

Main Methods:

  • Functional antibody profiling of Shigella-specific antibody isotypes, FcR binding, and antibody-mediated innate immune cell activation.
  • Analysis of longitudinal serum samples from culture-confirmed shigellosis patients (children and older individuals) in Bangladesh.
  • Assessment of antibody responses against O-specific polysaccharide (OSP) and protein antigens of Shigella.

Main Results:

  • Higher initial Shigella OSP-specific and protein-specific IgG and FcγR binding levels correlated with less severe disease across all ages.
  • Children under 5 years exhibited less robust, functional, and durable antibody responses compared to older individuals.
  • Functional *S. flexneri* 2a OSP-specific responses, promoting monocyte phagocytosis and activation, were significantly induced only in individuals over 5 years old.

Conclusions:

  • Young children with shigellosis mount antibody responses that inadequately activate monocytes, potentially impairing innate immune clearance.
  • The limited functional antibody response in young children may contribute to increased susceptibility to severe shigellosis.
  • Targeting mechanisms to enhance innate cell activation, particularly polymorphonuclear cell recruitment, could be key for effective Shigella vaccines in young children.